The dermo-cosmetic market is currently undergoing a major transformation, primarily driven by the integration of artificial intelligence (AI) into research and development processes. Pierre Fabre Laboratories are positioning themselves at the forefront of this transformation by using AI to optimize clinical studies, particularly in the treatment of acne. This initiative could potentially redefine industry standards and open new avenues for product innovation.